
Twelve years of multiples investors have paid for Yatharth Hospital & Trauma Care Services Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Yatharth Hospital & Trauma Care Services Ltd trades at a P/E of 46.10× and P/B of 4.51×.
Twelve years of audited numbers for Yatharth Hospital & Trauma Care Services Ltd, switchable between annual and quarterly views, consolidated or standalone.
Yatharth Hospital & Trauma Care Services Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹8,161.21 Cr and reported EPS of ₹18.20.
| Period | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue from Operations | 671 | 880 | 1,207 |
| Other Income | 16 | 16 | 26 |
| Total Income | 686 | 897 | 1,233 |
| Cost of Goods Sold (COGS) | 133 | 179 | 235 |
| Gross Profit | 537 | 702 | 973 |
| +Operating Expenses | 357 | 482 | 681 |
| EBITDA | 180 | 220 | 292 |
| +Non-Operating Expenses | 39 | 65 | 94 |
| Profit Before Tax (PBT) | 157 | 172 | 224 |
| +Tax Expense | 42 | 41 | 53 |
| Profit After Tax (PAT) | 114 | 131 | 170 |
| Earnings Per Share (EPS) | 13.33 | 13.55 | 17.67 |
| Diluted Shares Outstanding (Nos.) | 9 | 10 | 10 |
| +Additional Disclosures | 663 | 904 | 1,245 |
| Sales Growth % | — | 31.31 | 37.10 |
| YoY Sales Growth % | — | 31.31 | 37.10 |
| Material Cost % | 20 | 20 | — |
| Employee Cost % | 17 | 18 | 19 |
| Other Cost % | 36 | 36 | 37 |
| OPM % | 27 | 25 | 24 |
| Tax % | 27 | 24 | 24 |
| Profit Growth % | — | 14.04 | 30.45 |
| Gross Margin % | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 |
| Additional Fields | 151 | 163 | 204 |
Disclosed business segments at Yatharth Hospital & Trauma Care Services with their share of revenue and profit, switchable between consolidated and standalone reporting.
Yatharth Hospital & Trauma Care Services discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Yatharth Hospital & Trauma Care Services Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Yatharth Hospital & Trauma Care Services Ltd's investment case rests on 10 positive markers and 9 flagged concerns drawn from the latest reported filings.
Strong quarterly profit growth of 38.40% indicates robust operational efficiency.
High operating profit margin (OPM) of 54.46% reflects excellent cost management.
Very low debt-to-equity ratio of 0.01 ensures strong financial stability.
Consistent revenue growth, with 21.70% quarterly sales increase.
Impressive 5-year revenue growth CAGR of 43.24% demonstrates expansion.
High P/E ratio of 53.10 suggests potential overvaluation compared to earnings.
Negative annual cash flow per share (-16.73) raises liquidity concerns.
Promoter holdings decreased from 66.33% to 61.64%, warranting monitoring.
Absence of dividend yield (0.00%) may deter income-focused investors.
Recent stock price volatility, with daily changes up to 6.51% and -2.45%.
Trim if P/E re-rates above 60. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Yatharth Hospital & Trauma Care Services Ltd is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Yatharth Hospital & Trauma Care Services Ltd — derived from the live tape, not yesterday's close.
Yatharth Hospital & Trauma Care Services Ltd last traded at ₹845.15 with an intraday range of ₹821.9–₹847 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 904.33 | +59.18 | +7.00% |
| R3 | 879.23 | +34.08 | +4.03% |
| R2 | 863.12 | +17.97 | +2.13% |
| R1 | 854.13 | +8.98 | +1.06% |
| PIVOT | 838.02 | -7.13 | -0.84% |
| CURRENT | 845.15 | — | — |
| S1 | 778.83 | -66.32 | -7.85% |
| S2 | 803.93 | -41.22 | -4.88% |
| S3 | 812.92 | -32.23 | -3.81% |
| S4 | 829.03 | -16.12 | -1.91% |
YATHARTH is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 821.9 ~ 836
Trading Inside opening range
Auto-detected classical chart patterns for Yatharth Hospital & Trauma Care Services Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Daily traded volume and delivery percentage for Yatharth Hospital & Trauma Care Services Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Yatharth Hospital & Trauma Care Services Ltd stood at 53.5% of traded volume, against a 20-day average of 44.5%.
Filings Yatharth Hospital & Trauma Care Services sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Yatharth Hospital & Trauma Care Services files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 119 documents below.
We hereby submit intimation regarding Schedule of Investor Conference.
We hereby submit Earnings Call Transcript Q4 FY26.
We hereby submit Newspaper Publication of Financial Results - Q4 & FY26.
We hereby submit intimation regarding Schedule of Conference Call.
Every dividend, stock split and bonus issue Yatharth Hospital & Trauma Care Services has declared, sequenced by announce and record date.
Yatharth Hospital & Trauma Care Services corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Yatharth Hospital & Trauma Care Services Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Yatharth Hospital & Trauma Care Services Ltd operates in the Healthcare, listed as NSE: YATHARTH, BSE: 543950.

Yatharth Hospital & Trauma Care Services Limited is a healthcare provider operating multi-specialty hospitals in Delhi and Madhya Pradesh, India. The company's core business revolves around providing a wide range of medical services across numerous specialties, aiming to offer comprehensive care under one roof. Established in 2008 and based in Noida, the company has grown to encompass a substantial network of healthcare facilities.
Their services cover a vast spectrum of medical disciplines. This includes critical care, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics and spine surgery, rheumatology, plastic and cosmetic surgery, ENT, endocrinology, dermatology, nuclear medicine, oncology (including cancer and bone marrow transplant), gastrointestinal surgery and liver transplant, robotic surgery, IVF and fertility treatments, ophthalmology, dentistry, psychology and psychiatry, physiotherapy and rehabilitation, anesthesiology, radiology, pathology and laboratory medicine, and interventional spine and pain medicine. The breadth of specialties offered positions Yatharth as a significant player in the Indian healthcare market.
Beyond direct medical services, Yatharth also engages in ancillary businesses to support its hospital operations. These include the sale of medicines within their facilities and the operation of hospital canteens, providing convenient access to essential products and services for patients and staff. These secondary revenue streams contribute to the overall financial health of the company and enhance the patient experience.
In summary, Yatharth’s business model centers on providing high-quality, comprehensive healthcare services across a wide array of specializations. The company’s integrated approach, incorporating both core medical services and ancillary businesses, positions it to cater to a broad range of patient needs and contribute to the overall health and well-being of the communities it serves within India.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) is ₹845.15. Today, the stock has gained by ₹23.75 (2.89%), trading in a range of ₹821.9 to ₹847. The stock opened at ₹827 with a trading volume of 4,50,521 shares.
Yatharth Hospital & Trauma Care Services Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹8,161.21 crores, P/E ratio of 46.10, ROE of 10.40%, and ROCE of 12.40%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) is ₹889.9, while the 52-week low is ₹485. Currently trading at ₹845.15, the stock is 88.9% away from its 52-week low and 5.0% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Yatharth Hospital & Trauma Care Services Ltd stock at ₹845.15 depends on multiple factors. The stock is currently trading with a P/E ratio of 46.10 and P/B ratio of 4.51. Today's performance shows a gain of 2.89%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Yatharth Hospital & Trauma Care Services Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹845.15, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Yatharth Hospital & Trauma Care Services Ltd's key financial metrics include: P/E Ratio: 46.10, P/B Ratio: 4.51, ROE: 10.40%, ROCE: 12.40%, Dividend Yield: 0.00%, EPS: ₹18.20, Book Value: ₹185, and Debt-to-Equity: 0.15. The company's market cap stands at ₹8,161.21 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Yatharth Hospital & Trauma Care Services Ltd stock opened at ₹827 and is currently trading at ₹845.15, showing a gain of ₹23.75 (2.89%). The intraday high is ₹847 and low is ₹821.9. The trading volume stands at 4,50,521 shares, indicating moderate market participation today.
Yatharth Hospital & Trauma Care Services Ltd has a Price-to-Earnings (P/E) ratio of 46.10, which means investors are willing to pay ₹46.10 for every ₹1 of earnings. With an EPS of ₹18.20, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.